Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...

Brianne Gardner's 2025 stock picks

As you will see in the full video above, Brianne Gardner , senior wealth manager at Velocity Investments, Raymond James Canada reviews her past picks from September to see if they are on the money and she gives three new diversified picks for 2025 in healthcare, ener...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

Buzz on the Bullboards: Investor caution impacts market activity

The TSX began the week on a high note, buoyed by strength in the financial and industrial sectors. However, by Tuesday, the market had slipped into the red, as investor caution took hold ahead of the upcoming U.S. inflation data. Luckily for investors, things rebounded si...

Not only balloons: Use-cases and key players in global helium market

Whether you’re seeking exposure to exploration upside or established profitability, the helium market offers compelling candidates for the commodity sleeve of your portfolio. Helium is an essential resource notable for its widespread use-cases and p...

AI as a winning model!

200% return with Super Micro Computer and BlockchainK2; caution with Intel and Aixtron! The high-tech wave has been quite pronounced so far in 2024. Even the correction in July had little impact on the strong trend, which is now continuing upward. However, inve...

A world-class copper opportunity in Peru

The following is a transcription of the above video, and The Market Online has edited it for clarity . The Market Online recently caught up with Ivan Bebek, the co-founder and CEO of Coppernico Metals Inc , a mineral exploration company focused on creating value for...

Buzz on the Bullboards: From innovating traffic enforcement to cancer breakthroughs

The past week on the TSX has been one for the books, with significant gains driven largely by advancements in the technology sector. The S&P 500 and NASDAQ have hit fresh highs, a clear sign of a hungry market bolstered by technology stocks. This momentum has put a spot...

2024, a breakthrough year for silver

By Chen Lin, chenpicks.com For thousands of years, silver has been a globally recognized commodity. In China, silver was historically used as a standard form of currency, and the term “bank” in Chinese (银行) literally translates to “silver tradi...
1 2 3 4 5 6 7 8 9 10 ...